Rates of admission for respiratory syncytial virus (RSV) infection in children during their presumed periods of palivizumab prophylaxis
| No of children meeting criteria for prophylaxis | No admitted with RSV during prophylaxis | % admitted with RSV during prophylaxis | |
|---|---|---|---|
| CLD, Chronic lung disease. | |||
| CLD | 25 | 3 | 12.0 |
| ⩽28 weeks | 166 | 8 | 4.8 |
| 29–32 weeks | 395 | 16 | 4.1 |
| Total | 586 | 27 | 4.6 |